Score Overview
Explore the 2021 public Archive ranking →
Thermo Fisher Scientific Inc fundamental performance
Between 2005 and 2025, revenue grew from $ 2.63B to $ 44.55B and net income grew from $ 223M to $ 6.73B. Revenue increased in 18 of those 20 years; net income in 16.
Across Thermo Fisher Scientific Inc's full reported history, from 1985 to 2025, revenue grew from $ 265M to $ 44.55B and net income grew from $ 9M to $ 6.73B. Revenue increased in 85% of the years measured; net income in 77%.
Thermo Fisher Scientific Inc currently holds a 20-year HDB Score of 9.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-01 | $ 600.50 | — |
1 Year2025-08-29 | $ 490.93 | 22.32% |
5 Years2021-09-01 | $ 553.92 | 8.41% |
10 Years2016-09-01 | $ 146.70 | 309.34% |
20 Years2006-09-01 | $ 37.09 | 16x |
30 Years1996-08-30 | $ 32.22 | 18x |
| Period | Last Price2026-09-01 | 1 Year2025-08-29 | 5 Years2021-09-01 | 10 Years2016-09-01 | 20 Years2006-09-01 | 30 Years1996-08-30 |
|---|---|---|---|---|---|---|
| Price | $ 600.50 | $ 490.93 | $ 553.92 | $ 146.70 | $ 37.09 | $ 32.22 |
| Return | — | 22.32% | 8.41% | 309.34% | 16x | 18x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 46.33B | $ 6.97B | $ 4.06B |
| 2025 | $ 44.55B | $ 6.73B | $ 10.10B |
| 2024 | $ 42.87B | $ 6.33B | $ 5.58B |
| 2023 | $ 42.85B | $ 5.99B | $ 8.08B |
| 2022 | $ 44.91B | $ 6.95B | $ 8.52B |
| 2021 | $ 39.21B | $ 7.72B | $ 4.47B |
| 2020 | $ 32.21B | $ 6.37B | $ 10.32B |
| 2019 | $ 25.54B | $ 3.69B | $ 2.39B |
| 2018 | $ 24.35B | $ 2.93B | $ 2.10B |
| 2017 | $ 20.91B | $ 2.22B | $ 1.33B |
| 2016 | $ 18.27B | $ 2.02B | $ 786M |
| 2015 | $ 16.96B | $ 1.97B | $ 452M |
| 2014 | $ 16.88B | $ 1.89B | $ 1.34B |
| 2013 | $ 13.09B | $ 1.27B | $ 5.83B |
| 2012 | $ 12.50B | $ 1.17B | $ 809M |
| 2011 | $ 11.72B | $ 1.32B | $ 1.02B |
| 2010 | $ 10.78B | $ 1.03B | $ 926M |
| 2009 | $ 10.10B | $ 850M | $ 1.57B |
| 2008 | $ 10.49B | $ 994M | $ 1.28B |
| 2007 | $ 9.74B | $ 761M | $ 639M |
| 2006 | $ 3.79B | $ 168M | $ 691M |
| 2005 | $ 2.63B | $ 223M | $ 294M |
| 2004 | $ 2.20B | $ 361M | $ 512M |
| 2003 | $ 2.09B | $ 200M | $ 418M |
| 2002 | $ 2.08B | $ 309M | $ 875M |
| 2001 | $ 2.18B | $ 1.04B | |
| 2000 | $ 2.28B | -$ 36M | $ 1.02B |
| 1999 | $ 2.47B | -$ 174M | $ 838M |
| 1998 | $ 3.86B | $ 181M | $ 1.54B |
| 1997 | $ 3.55B | $ 239M | $ 1.52B |
| 1996 | $ 2.93B | $ 190M | $ 1.84B |
| 1995 | $ 2.20B | $ 140M | $ 1.05B |
| 1994 | $ 1.58B | $ 103M | $ 382M |
| 1993 | $ 1.24B | $ 76M | $ 325M |
| 1992 | $ 949M | $ 59M | $ 190M |
| 1991 | $ 805M | $ 47M | $ 131M |
| 1990 | $ 708M | $ 33M | $ 117M |
| 1989 | $ 579M | $ 24M | $ 93M |
| 1988 | $ 500M | $ 20M | $ 136M |
| 1987 | $ 383M | $ 18M | $ 144M |
| 1986 | $ 331M | $ 14M | $ 63M |
| 1985 | $ 265M | $ 9M | $ 30M |
Where Thermo Fisher Scientific Inc has ranked, year by year
Each point is that year's ranking on ten years of fundamentals, as a share of every company we could rank at the time. Higher is better. We show the share rather than the place because the number of companies grows — 193 in 1996, 2,060 in 2021 — so the same place means something different at either end.
Top 50 on HDB Score for 2 consecutive years, since 2020.
1996: 1.6% · 2021: 0.6% · free through 2021 · longest runs
See where TMO ranks today
You're looking at Thermo Fisher Scientific Inc's public company record. Membership adds the current comparative layer and continues its ranking history through recent years.
- Current market-wide rankings across 3,839 covered companies
- See where Thermo Fisher Scientific Inc ranks today
- Complete current Score Views across every period
- Current Tenure and recent Archive years
- Portfolio and member features
$99/year $149 founding price
Become a Member30-day money-back guarantee.
